FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093469 [Registered on: 22/08/2025] Trial Registered Prospectively
Last Modified On: 21/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Rajarasayan in treatment of Pratishyay in children 
Scientific Title of Study   Evaluation of efficacy of Rajrasayan verses Vachadi Avaleha in the Management of Pratishyaya (Rhinitis) in School going Children : A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR PRIYANKA PRASHANT MUNJEWAR 
Designation  PG SCHOLAR 
Affiliation  Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod(H) Wardha 
Address  Room No 41, Department of Kaumarbhritya, Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod Hirapur Wardha. MAHARASHTRA 442001 India Wardha MAHARASHTRA 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  8390963886  
Fax    
Email  dr.priyankamunjewar12@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rahul M Jumle 
Designation  PROFESSOR 
Affiliation  Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod(H) Wardha 
Address  Room No 41, Department of Kaumarbhritya, Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod Hirapur Wardha. MAHARASHTRA 442001 India Wardha MAHARASHTRA 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  9766643990  
Fax    
Email  rahul.kaumarbhritya@dmiher.edu.in  
 
Details of Contact Person
Public Query
 
Name  DR PRIYANKA PRASHANT MUNJEWAR 
Designation  PG SCHOLAR 
Affiliation  Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod(H) Wardha 
Address  Room No 41, Department of Kaumarbhritya, Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod Hirapur Wardha. MAHARASHTRA 442001 India Wardha MAHARASHTRA 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  8390963886  
Fax    
Email  dr.priyankamunjewar12@gmail.com  
 
Source of Monetary or Material Support  
Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod(H), Wardha Dist Wardha Maharashtra, India 442001 
 
Primary Sponsor  
Name  Mahatma Gandhi Ayurved College, Hospital and Research Centre 
Address  Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod(H) Wardha, MAHARASHTRA 442001 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR PRIYANKA PRASHANT MUNJEWAR  Mahatma Gandhi Ayurved College, Hospital and Research Centre, Salod(H) Wardha  Room No 41, Department of Kaumarbhritya, Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod(H) Wardha. MAHARASHTRA 442001 India Wardha MAHARASHTRA
Wardha
MAHARASHTRA 
8390963886

dr.priyankamunjewar12@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma Gandhi Ayurved College, Hospital and Research Centre Institutional Committee, Salod(H) Wardha, Maharashtra 442001  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J300||Vasomotor rhinitis. Ayurveda Condition: PRATISYAYAH/PINASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Vachadi Avaleha, Reference: Harita Samhita 3rd sthana 2/49, Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Koshna Jal), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Rajarasayan, Reference: Vangasen Samhita Part 1 Nasaroga Adhyay 35-37, Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: koshna jal), Additional Information:
 
Inclusion Criteria  
Age From  4.00 Year(s)
Age To  18.00 Year(s)
Gender  Both 
Details  Patients suffering from Pratishaya less than 3-4 days
Patients in the age group of 4 year to 18 years will be selected irrespective of sex, socio-economic status and religion
Children whose parents are giving written consent for their child to participate in the study 
 
ExclusionCriteria 
Details  Mucoid and purulent or blood-stained nasal discharge
Patient suffering from nasal polyps, Deviated nasal septum
Any other systemic illness for eg. Fever
Rhinitis associated with immunodeficiency like HIV  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To assess the reduction in the symptoms of pratishyaya on the basis of subjective and objective criteria.  Treatment for 7 days and post treatment follow up on 14th and 21st day. 
 
Secondary Outcome  
Outcome  TimePoints 
To assses the recurrence of pratishyaya in school going children.  Follow up on 14th & 21st day. 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   10/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The volunteers will be informed about the study protocol. Willing participants will be randomly
 selected as per computer-generated table. The clinical research format will be prepared
 and validated.Before the study approval will be taken from IEC, MGACHRC, Salod (H) Wardha, and CTRI
 registration will be done. After selection, each participant will be tested individually and selected
 according to selection criteria. They are divided into two groups. The trial is a Randomized Single blind clinical control trial.
 
Close